Osama Ali
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Osama Ali has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Elliot K. Fishman
Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins School of Medicine, Johns Hopkins University, 601 N. Caroline Street/JHOC 3235A, Baltimore, MD, 21287, USA
2 shared publications- Ali Ahmad
Mayo Clinic
1 shared publication - Ann W. Silk
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
1 shared publication - Aron-Frederik Popov
Clinic for Cardiac Surgery, Asklepios Clinic Harburg, Hamburg, Germany
1 shared publication Bernd C. Danner
Department of Cardiothoracic and Vascular Surgery, Universitätsmedizin Göttingen, Göttingen, Germany
1 shared publication- Elliot K. Fishman
Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, 601 N Caroline St, Baltimore, MD 21287, USA
1 shared publication
Latest Publications
- Open Access
- 5 March 2020
- Published by Egyptian Knowledge Bank in Al-Azhar International Medical Journal
- p. 183-189
Role of Measurement of Placental Thickness and Diameter at the Third Trimester Using Two Dimensional Ultrasound in Determination of Low Birth Weight
Background: Birth weight is the first weight of the fetus or newborn obtained after birth preferably measured within the first hour of life before significant postnatal weight loss has occurred. Aim of the work: This study was conducted in order to assess the role of measurement of placental thickness and diameter at the third trimester using two dimensional ultrasound in determination of low birth weight. Patients and methods: This study was carried out at Sayed Galal University Hospital and Damanhour Teaching Hospital on "400" uncomplicated pregnant women who was attend the outpatient clinic at Sayed Galal University Hospital and Damanhour Teaching Hospital, two dimensional ultrasound measurement of placental thickness and diameter was done to assess its role in determination of low birth weight. Results: The results of this study show that there were significant positive correlations between neonatal weight and GA, Placental diameter, Placental thickness, Biparietal diameter, Femur length & Abdominal circumference (P < 0.05), while there was no statistical significant difference regarding maternal age (P > 0.05). Also our results shows that there was no statistical significant difference according to parity regarding fetal and placental measures. The results show that there was no statistical significant difference according to fetal sex regarding placental measures (P > 0.05). Conclusion: The result of this study shows a strong positive correlation between neonatal weight and placental thickness, so placental thickness measured at the level of umbilical cord insertion can be used as an accurate sonographic indicator in the assessment of fetal weight.
- 5 March 2020
- Published by Egyptian Knowledge Bank in Al-Azhar International Medical Journal
- p. 183-189
Open AccessRole of Measurement of Placental Thickness and Diameter at the Third Trimester Using Two Dimensional Ultrasound in Determination of Low Birth Weight
Background: Birth weight is the first weight of the fetus or newborn obtained after birth preferably measured within the first hour of life before significant postnatal weight loss has occurred. Aim of the work: This study was conducted in order to assess the role of measurement of placental thickness and diameter at the third trimester using two dimensional ultrasound in determination of low birth weight. Patients and methods: This study was carried out at Sayed Galal University Hospital and Damanhour Teaching Hospital on "400" uncomplicated pregnant women who was attend the outpatient clinic at Sayed Galal University Hospital and Damanhour Teaching Hospital, two dimensional ultrasound measurement of placental thickness and diameter was done to assess its role in determination of low birth weight. Results: The results of this study show that there were significant positive correlations between neonatal weight and GA, Placental diameter, Placental thickness, Biparietal diameter, Femur length & Abdominal circumference (P < 0.05), while there was no statistical significant difference regarding maternal age (P > 0.05). Also our results shows that there was no statistical significant difference according to parity regarding fetal and placental measures. The results show that there was no statistical significant difference according to fetal sex regarding placental measures (P > 0.05). Conclusion: The result of this study shows a strong positive correlation between neonatal weight and placental thickness, so placental thickness measured at the level of umbilical cord insertion can be used as an accurate sonographic indicator in the assessment of fetal weight.
- 14 November 2019
- Published by Springer Nature in Abdominal Radiology
- Vol. 45 (3) , 889
Correction to: Upper urinary tract urothelial carcinoma on multidetector CT: spectrum of disease
The original version of this article contained an error in one of the author name. The co-author name was published as “Elliot Fishman”, instead it should be “Elliot K. Fishman”. The original article...
- 14 November 2019
- Published by Springer Nature in Abdominal Radiology
- Vol. 45 (3) , 889
Correction to: Upper urinary tract urothelial carcinoma on multidetector CT: spectrum of disease
The original version of this article contained an error in one of the author name. The co-author name was published as “Elliot Fishman”, instead it should be “Elliot K. Fishman”. The original article...
- 22 August 2019
- Published by Springer Nature in Abdominal Radiology
- Vol. 44 (12) , 3874-3885
Upper urinary tract urothelial carcinoma on multidetector CT: spectrum of disease
Urothelial carcinoma of the upper urinary tract (UUT) is a relatively uncommon genitourinary malignancy, accounting for about 5–7% of urothelial tumors. The significant features of this tumor are multifocality and high rate of recurrence. Computed tomography urography (CTU) has replaced excretory urography (EU) and retrograde pyelography (RP) for imaging of upper tract urothelial carcinoma. While many studies have confirmed high sensitivity (88–100%) and specificity (93–100%) of CTU, an optimized CT protocol is of critical importance in screening, staging, and post-operative follow-up of patients (Chlapoutakis, Eur J Radiol 73(2):334–338, 2010; Caoli and Cohan, Abdom Radiol (NY) 41(6):1100–1107, 2016). The key element of the CT protocol is to have adequate distension of the collecting system with excreted contrast, to detect subtle lesions at an early stage. In this article, we discuss the background of upper urinary tract TTC, pathogenesis, CT protocol and the role of imaging in evaluation of this malignancy, staging, as well as different imaging appearances.
- 22 August 2019
- Published by Springer Nature in Abdominal Radiology
- Vol. 44 (12) , 3874-3885
Upper urinary tract urothelial carcinoma on multidetector CT: spectrum of disease
Urothelial carcinoma of the upper urinary tract (UUT) is a relatively uncommon genitourinary malignancy, accounting for about 5–7% of urothelial tumors. The significant features of this tumor are multifocality and high rate of recurrence. Computed tomography urography (CTU) has replaced excretory urography (EU) and retrograde pyelography (RP) for imaging of upper tract urothelial carcinoma. While many studies have confirmed high sensitivity (88–100%) and specificity (93–100%) of CTU, an optimized CT protocol is of critical importance in screening, staging, and post-operative follow-up of patients (Chlapoutakis, Eur J Radiol 73(2):334–338, 2010; Caoli and Cohan, Abdom Radiol (NY) 41(6):1100–1107, 2016). The key element of the CT protocol is to have adequate distension of the collecting system with excreted contrast, to detect subtle lesions at an early stage. In this article, we discuss the background of upper urinary tract TTC, pathogenesis, CT protocol and the role of imaging in evaluation of this malignancy, staging, as well as different imaging appearances.
- Open Access
- 8 July 2019
- Published by BMJ in Journal for ImmunoTherapy of Cancer
- Vol. 7 (1) , 170
Rescue therapy for patients with anti-PD-1-refractory Merkel cell carcinoma: a multicenter, retrospective case series
Merkel cell carcinoma (MCC) is a rare but clinically aggressive cancer with a high mortality rate. In recent years, antibodies blocking the interactions among PD-1 and its ligands have generated durable tumor regressions in patients with advanced MCC. However, there is a paucity of data regarding effective therapy for patients whose disease is refractory to PD-1 pathway blockade. This retrospective case series describes a heterogeneous group of patients treated with additional immune checkpoint blocking therapy after MCC progression through anti-PD-1. Among 13 patients treated with anti-CTLA-4, alone or in combination with anti-PD-1, objective responses were seen in 4 (31%). Additionally, one patient with MCC refractory to anti-PD-1 and anti-CTLA-4 experienced tumor regression with anti-PD-L1. Our report – the largest case series to date describing this patient population – provides evidence that sequentially-administered salvage immune checkpoint blocking therapy can potentially activate anti-tumor immunity in patients with advanced anti-PD-1-refractory MCC and provides a strong rationale for formally testing these agents in multicenter clinical trials. Additionally, to the best of our knowledge, our report is the first to demonstrate possible anti-tumor activity of second-line treatment with a PD-L1 antibody in a patient with anti-PD-1-refractory disease.
- 8 July 2019
- Published by BMJ in Journal for ImmunoTherapy of Cancer
- Vol. 7 (1) , 170
Open AccessRescue therapy for patients with anti-PD-1-refractory Merkel cell carcinoma: a multicenter, retrospective case series
Merkel cell carcinoma (MCC) is a rare but clinically aggressive cancer with a high mortality rate. In recent years, antibodies blocking the interactions among PD-1 and its ligands have generated durable tumor regressions in patients with advanced MCC. However, there is a paucity of data regarding effective therapy for patients whose disease is refractory to PD-1 pathway blockade. This retrospective case series describes a heterogeneous group of patients treated with additional immune checkpoint blocking therapy after MCC progression through anti-PD-1. Among 13 patients treated with anti-CTLA-4, alone or in combination with anti-PD-1, objective responses were seen in 4 (31%). Additionally, one patient with MCC refractory to anti-PD-1 and anti-CTLA-4 experienced tumor regression with anti-PD-L1. Our report – the largest case series to date describing this patient population – provides evidence that sequentially-administered salvage immune checkpoint blocking therapy can potentially activate anti-tumor immunity in patients with advanced anti-PD-1-refractory MCC and provides a strong rationale for formally testing these agents in multicenter clinical trials. Additionally, to the best of our knowledge, our report is the first to demonstrate possible anti-tumor activity of second-line treatment with a PD-L1 antibody in a patient with anti-PD-1-refractory disease.
- 1 October 2018
- Published by Elsevier in European Journal of Radiology
- Vol. 107, 134-142
Recurrent renal cell carcinoma following nephrectomy and ablation therapy: Radiology perspective
- 1 October 2018
- Published by Elsevier in European Journal of Radiology
- Vol. 107, 134-142
Recurrent renal cell carcinoma following nephrectomy and ablation therapy: Radiology perspective
- Open Access
- 29 May 2008
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 394 (2) , 357-362
Extravascular perivenous fibrin support leads to aneurysmal degeneration and intimal hyperplasia in arterialized vein grafts in the rat
Background and aims External support of vein grafts by fibrin glue possibly prevents overdistension, vascular remodeling, and neointimal hyperplasia. Previous animal models of neointimal hyperplasia showed conflicting results. Here, long-term effects of external fibrin glue support were studied in a new rat model of jugular vein to abdominal aorta transposition. Materials and methods and methods In male Wistar rats (250–300 g) right jugular vein (1.0–1.5 cm) was transposed to the infrarenal aorta. Fibrin glue (0.25 ml) covered the vein before releasing the vascular clamps (n = 6). Control vein grafts were exposed directly to blood pressure. After 16 weeks vein grafts were pressure-fixed for histology. Intima thickness, luminal and intimal area were measured by planimetry and elastic fibers demonstrated by Elastica van Giesson staining. Results Intimal thickness (74.04 ± 6.7 µm vs 1245 ± 187 µm, control vs fibrin treatment; p < 0.001), intimal area (2517.16 ± 355 mm2 vs 18424 ± 4927 mm2, control vs fibrin treatment; p < 0.05) and luminal area (2184.75 ± 347 mm2 vs 7231.85 ± 1782 mm2, control vs fibrin treatment; p < 0.05) were significantly increased, elastic fibers in the vessel wall were diminished and the vessel wall infiltrated by mononuclear cells in fibrin glue supported veins. Conclusion External support of vein grafts by fibrin glue leads to aneurysmal degeneration and intimal hyperplasia, thereby possibly jeopardizing long-term graft patency.
- 29 May 2008
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 394 (2) , 357-362
Open AccessExtravascular perivenous fibrin support leads to aneurysmal degeneration and intimal hyperplasia in arterialized vein grafts in the rat
Background and aims External support of vein grafts by fibrin glue possibly prevents overdistension, vascular remodeling, and neointimal hyperplasia. Previous animal models of neointimal hyperplasia showed conflicting results. Here, long-term effects of external fibrin glue support were studied in a new rat model of jugular vein to abdominal aorta transposition. Materials and methods and methods In male Wistar rats (250–300 g) right jugular vein (1.0–1.5 cm) was transposed to the infrarenal aorta. Fibrin glue (0.25 ml) covered the vein before releasing the vascular clamps (n = 6). Control vein grafts were exposed directly to blood pressure. After 16 weeks vein grafts were pressure-fixed for histology. Intima thickness, luminal and intimal area were measured by planimetry and elastic fibers demonstrated by Elastica van Giesson staining. Results Intimal thickness (74.04 ± 6.7 µm vs 1245 ± 187 µm, control vs fibrin treatment; p < 0.001), intimal area (2517.16 ± 355 mm2 vs 18424 ± 4927 mm2, control vs fibrin treatment; p < 0.05) and luminal area (2184.75 ± 347 mm2 vs 7231.85 ± 1782 mm2, control vs fibrin treatment; p < 0.05) were significantly increased, elastic fibers in the vessel wall were diminished and the vessel wall infiltrated by mononuclear cells in fibrin glue supported veins. Conclusion External support of vein grafts by fibrin glue leads to aneurysmal degeneration and intimal hyperplasia, thereby possibly jeopardizing long-term graft patency.